Dose Expansion Results Of The Bifunctional Egfr/Tgfb Inhibitor Bca101 With Pembrolizumab In Patients With Recurrent, Metastatic Head And Neck Squamous Cell Carcinoma
BCA101;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Dose Expansion Results Of The Bifunctional Egfr/Tgfb Inhibitor Bca101 With Pembrolizumab In Patients With Recurrent, Metastatic Head And Neck Squamous Cell Carcinoma ### Output: BCA101;Pembrolizumab